NUELIN

This brand name is authorized in Australia, Hong Kong SAR China, New Zealand, Singapore, South Africa.

Active ingredients

The drug NUELIN contains one active pharmaceutical ingredient (API):

1	Theophylline UNII C137DTR5RG - THEOPHYLLINE
	Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output.
	Read more about Theophylline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NUELIN SR Tablet / NUELIN Syrup	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03DA04	Theophylline	R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DA Xanthines
Discover more medicines within R03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2614N, 2634P, 8230E, 8231F
HK	Department of Health Drug Office	19118, 19359, 35060, 45831, 45832
NZ	Medicines and Medical Devices Safety Authority	2018, 2021
SG	Health Sciences Authority	02770P, 10679P, 11399P
ZA	Health Products Regulatory Authority	33/10.2/0416, 33/10.2/0417, H/10.2/296, P/10.2/54, S/10.2/126